Основные характеристики влюченных исследований

АГ - артериальная гипертензия, МАУ - микроальбуминурия, ТИА - транзиторная ишемическая атака, АД - артериальное давление, НТГ - нарушение толерантности к глюкозе, БРА - блокатор рецепторов ангиотензина; ИАПФ - ингибитор ангиотензин-превращающего фермента; ИБС - ишемическая болезнь сердца; СД - сахарный диабет; СС - сердечно-сосудистые; NA - нет данных; AIPRI - Angiotensin-converting enzyme Inhibition in Progressive Renal Insufficiency; CAMELOT - Comparison of AMlodipine vs Enalapril to Limit Occurrences of Thrombosis; DIABHYCAR - type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril; DIRECT - DIabetic REtinopathy Candesartan Trials; DREAM - Diabetes REduction Assessment with ramipril and rosiglitazone Medication; EUROPA - in the EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease; HOPE - Heart Outcomes Prevention Evaluation; PART-2 - Prevention of Atheroslerosis with Ramipril Trial; IDNT - Irbesartan Diabetic Nephropathy Trial; IMAGINE - Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme; IRMA-2 - IRbesartan MicroAlbuminuria type 2 diabetes mellitus in hypertensive patients; MMSE - Mini Mental State Examination; NAVIGATOR - Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research; ORIENT - Olmesartan Reducing Incidence of End stage renal disease in diabetic Nephropathy Trial; PEACE - Prevention of Events with Angiotensin Converting Enzyme inhibition; PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes; PROGRESS - Perindopril pROtection aGainst REcurrent Stroke Study; QUIET - QUinapril Ischemic Event Trial; RENAAL - Reduction in ENdpoints with the Angiotensin Antagonist Losartan; ROADMAP - Randomized Olmesartan And Diabetes MicroAlbuminuria Prevention; SCAT - Simvastatin/enalapril Coronary Atheroslerosis Trial; SCOPE - Study on Cognition and Prognosis in the Elderly; TRASCEND - Telmisartan Randomised AssessmeNT Study in ACEiNtoleran subjects with cardiovascular Disease

Таблица 2.